TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/27/2025
Back to search
Official data from USPTO
MISSION PHARMACAL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
MISSION PHARMACAL
ST13
US500000076123057Class
5, 10
Filing
76123057
Registration
2558250
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
39
Latest update
04/02/2025
Trademark type
Word
Nice classes
5, 10
Filing date
09/06/2000
Registration date
04/09/2002
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/29/2022
Last transaction
04/02/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
01/01/1996
First use in commerce
01/01/1996
Drawing code
1
Owner type
03
Owner location
SAN ANTONIO, TX
Examiner
MCMORROW, RONALD
Law office
L50
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
MISSION PHARMACAL COMPANY
MISSION PHARMACAL COMPANY
Representatives
Pamela B. Huff Schwegman Lundberg & Woessner P.A.
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Vitaminsminerals and dietary supplements; Diagnostic test kits comprised primarily of a plastic collection container with chemically impregnated sponges and sample vials for use in kidney stone urinalysis; Gels for use as a personal and surgical lubricant; Pharmaceutical preparations for the treatment or prevention of osteoporosiskidney and genito-urinary tract complicationscardiovascular complicationsgastrointestinal complicationsdental complicationsanemiapregnancy and lactation complicationscancerelectrolyte imbalancemyalgiaarthralgiapain and fatigue
Class 10
Vacuum constriction devices for use in the treatment of impotency
Publications
History of USPTO decisions and trademark events.
39 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/27/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/27/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/27/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/27/2025
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
08/29/2022
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
08/29/2022
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
08/29/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/29/2022
E89R
TEAS SECTION 8 & 9 RECEIVED
03/09/2022
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
04/09/2021
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
03/03/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/08/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/08/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/08/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/08/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/08/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/07/2017
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
02/28/2012
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
02/28/2012
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
02/28/2012
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/28/2012
E89R
TEAS SECTION 8 & 9 RECEIVED
01/24/2012
C15P
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
04/28/2008
PLGL
ASSIGNED TO PARALEGAL
04/24/2008
815F
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
04/08/2008
E815
TEAS SECTION 8 & 15 RECEIVED
04/08/2008
CFIT
CASE FILE IN TICRS
05/25/2007
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/21/2003
PAPER RECEIVED
12/09/2002
PAPER RECEIVED
11/07/2002
R.PR
REGISTERED-PRINCIPAL REGISTER
04/09/2002
PUBO
PUBLISHED FOR OPPOSITION
01/15/2002
NPUB
NOTICE OF PUBLICATION
12/26/2001
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/24/2001
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/06/2001
CNRT
NON-FINAL ACTION MAILED
02/02/2001
DOCK
ASSIGNED TO EXAMINER
01/29/2001
DOCK
ASSIGNED TO EXAMINER
01/23/2001
Continuous trademark protection
Get notified about every new filing that threatens MISSION PHARMACAL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.